1型自身免疫性胰腺炎的CT监测:累积辐射剂量与疾病复发的诊断效能
回顾性单中心研究纳入247例接受CT随访的1型自身免疫性胰腺炎患者及120例MRI随访患者。CT随访中位累积辐射剂量37.5 mSv,11.3%患者超过100 mSv;CT检测腹部器官复发的敏感度/特异度/准确率为64.1%/99.6%/97.0%,MRI随访患者复发检测敏感度为90.5%。
要点
- 1型自身免疫性胰腺炎长期CT监测累积辐射剂量中位37.5 mSv,11.3%患者超过100 mSv。
- CT检测腹部器官复发的敏感度仅64.1%,特异度99.6%,准确率97.0%。
- MRI随访患者复发检测敏感度为90.5%,高于CT。
核心结论
- 考虑到1型自身免疫性胰腺炎患者辐射剂量累积及CT检测疾病复发敏感度不足,应探索更安全、更敏感的影像随访策略。
研究设计与样本
- 回顾性单中心研究,纳入247例有至少一次CT随访的1型自身免疫性胰腺炎患者和120例有MRI随访的患者,以回顾性最终临床诊断作为参考标准。
诊断标准与关键数值
- CT检测腹部器官复发的敏感度64.1%、特异度99.6%、准确率97.0%;MRI随访患者复发检测敏感度90.5%;CT随访中位累积辐射剂量37.5 mSv,11.3%患者超过100 mSv;随访超过1年的169例患者中30.8%年均辐射剂量超过20 mSv。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Long-term follow-up is essential for type 1 autoimmune pancreatitis (AIP) patients due to high relapse rates. The cumulative radiation dose from repeated CT scans during follow-up should not be ignored. We aim to investigate the cumulative radiation dose in AIP patients undergoing CT surveillance and the diagnostic performance of CT in detecting disease relapse. The diagnostic performance of MRI from a secondary cohort during the same period was also investigated.
METHODS: This retrospective single-institutional study included 247 type 1 AIP patients with one or more follow-up CT scans, and 120 patients with MR follow-ups. Four metrics were utilized to report the radiation dose, including the volume computed tomography dose index, the dose length product, size-specific dose estimate and effective dose. The diagnostic performance for AIP relapse was assessed, taking the final clinical diagnosis in retrospect as the reference standard.
RESULTS: With a median 2.3-year follow-up period, AIP patients followed up with CT exhibited a median cumulative radiation dose of 37.5 mSv. 11.3% of patients have accumulated doses exceeding 100 mSv. For the 169 patients followed over a year, 30.8% sustained an average annual radiation dose surpassing 20 mSv. The sensitivity/specificity/accuracy of CT for detecting abdominal organ relapse was 64.1%/99.6%/97.0%. For AIP patients followed up with MRI, the sensitivity for detecting disease relapse was 90.5%.
CONCLUSION: Considering the accumulation of radiation dose in AIP patients and the insufficient sensitivity in detecting disease relapse with CT, safer and more sensitive imaging follow-up strategies should be explored.
KEY POINTS: Question CT, as the primary imaging modality for autoimmune pancreatitis (AIP) follow-up, raises concerns regarding radiation exposure and lacks reported diagnostic performance in detecting AIP relapse. Findings CT in AIP follow-up causes significant cumulative radiation exposure and exhibits insufficient sensitivity in relapse detection. Clinical relevance Type 1 AIP necessitates long-term imaging follow-up, yet current guidelines lack consensus regarding the prioritization of CT or MRI for such follow-up. CT is widely used but has radiation concerns and limited sensitivity, calling for safer, efficient strategies.
引用
- Liu JY, Zhu L, Xue HD, et al. CT surveillance for type 1 autoimmune pancreatitis: cumulative radiation dose and diagnostic performance for disease relapse. Eur Radiol. 2024. PMID: 39485517. doi:10.1007/s00330-024-11161-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。